[{"address1": "3655 Nobel Drive", "address2": "Suite 260", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "858 926 7655", "website": "https://darebioscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dar\u00e9 Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a vaginal thermosetting gel formulation for the delivery of live biotherapeutics; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Dar\u00e9 Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Ms. Sabrina Martucci Johnson", "age": 58, "title": "CEO, President, Principal Financial Officer, Secretary & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 641406, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. MarDee J. Haring-Layton", "age": 49, "title": "Chief Accounting Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 409800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Walters", "age": 70, "title": "Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Friend Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jennifer  Kiang", "title": "Vice President of Corporate Affairs & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.9, "open": 1.92, "dayLow": 1.78, "dayHigh": 1.92, "regularMarketPreviousClose": 1.9, "regularMarketOpen": 1.92, "regularMarketDayLow": 1.78, "regularMarketDayHigh": 1.92, "payoutRatio": 0.0, "beta": 0.784, "forwardPE": -5.1714287, "volume": 185871, "regularMarketVolume": 185871, "averageVolume": 160751, "averageVolume10days": 65980, "averageDailyVolume10Day": 65980, "bid": 1.37, "ask": 2.31, "bidSize": 2, "askSize": 2, "marketCap": 24397898, "fiftyTwoWeekLow": 1.61, "fiftyTwoWeekHigh": 9.19, "allTimeHigh": 1304.4, "allTimeLow": 1.61, "priceToSalesTrailing12Months": -427.0593, "fiftyDayAverage": 1.9561, "twoHundredDayAverage": 2.318875, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 5720789, "profitMargins": 0.0, "floatShares": 13041208, "sharesOutstanding": 13479502, "sharesShort": 361373, "sharesShortPriorMonth": 466123, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0253, "heldPercentInsiders": 0.087340005, "heldPercentInstitutions": 0.080970004, "shortRatio": 2.35, "shortPercentOfFloat": 0.0255, "impliedSharesOutstanding": 13479502, "bookValue": 0.205, "priceToBook": 8.829268, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -17463954, "trailingEps": -1.83, "forwardEps": -0.35, "lastSplitFactor": "1:12", "lastSplitDate": 1719792000, "enterpriseToRevenue": -100.136, "enterpriseToEbitda": -0.35, "52WeekChange": -0.39682537, "SandP52WeekChange": 0.16255379, "quoteType": "EQUITY", "currentPrice": 1.81, "targetHighPrice": 12.0, "targetLowPrice": 8.0, "targetMeanPrice": 10.75, "targetMedianPrice": 11.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 23075260, "totalCashPerShare": 1.615, "ebitda": -16362804, "totalDebt": 2932546, "quickRatio": 1.105, "currentRatio": 1.179, "totalRevenue": -57130, "debtToEquity": 102.612, "revenuePerShare": -0.006, "returnOnAssets": -0.4474, "returnOnEquity": -25.431341, "grossProfits": -14354664, "freeCashflow": -938184, "operatingCashflow": -6103524, "revenueGrowth": -0.946, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -1623.4077, "financialCurrency": "USD", "symbol": "DARE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekChangePercent": -39.682537, "dividendDate": 1500508800, "postMarketChangePercent": -0.08286692, "postMarketPrice": 1.8085, "postMarketChange": -0.0014998913, "regularMarketChange": -0.09000003, "regularMarketDayRange": "1.78 - 1.92", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 160751, "fiftyTwoWeekLowChange": 0.19999993, "fiftyTwoWeekLowChangePercent": 0.12422356, "fiftyTwoWeekRange": "1.61 - 9.19", "fiftyTwoWeekHighChange": -7.3799996, "fiftyTwoWeekHighChangePercent": -0.80304676, "shortName": "Dare Bioscience, Inc.", "longName": "Dar\u00e9 Bioscience, Inc.", "corporateActions": [], "postMarketTime": 1769820188, "regularMarketTime": 1769806800, "exchange": "NCM", "messageBoardId": "finmb_423979060", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.736844, "regularMarketPrice": 1.81, "marketState": "CLOSED", "earningsTimestamp": 1763067600, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "earningsCallTimestampStart": 1763069400, "earningsCallTimestampEnd": 1763069400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.83, "epsForward": -0.35, "epsCurrentYear": -1.655, "priceEpsCurrentYear": -1.0936556, "fiftyDayAverageChange": -0.14610004, "fiftyDayAverageChangePercent": -0.074689455, "twoHundredDayAverageChange": -0.50887513, "twoHundredDayAverageChangePercent": -0.21944913, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1397136600000, "displayName": "Dar\u00e9 Bioscience", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]